Bar Plot from Scientific Research

Genome editing activity of optimized VSVG-pseudotyped Cas9-EDVs in activated primary human T cells. B2M or TRAC genome editing was assessed by amplicon sequencing 7 days post treatment; n = 3 technical replicates were assessed for all conditions except for the untreated resting human T cells (n = 2).

DOI